The Fate of FTC v. Actavis, Inc. in the Biosimilar Context-Does and Should the FTC v. Actavis Decision Apply to Reverse Patent Settlements Between Brand Drug and Biosimilar Manufacturers?-MedSci.cn

The Fate of FTC v. Actavis, Inc. in the Biosimilar Context-Does and Should the FTC v. Actavis Decision Apply to Reverse Patent Settlements Between Brand Drug and Biosimilar Manufacturers?

Ho, NG

BIOTECHNOLOGY LAW REPORT, 2022; 41 (4): 194

科室
- - 订阅+
  - 更多科室
工具
服务